CAMBRIDGE, Mass., Jan. 3 /PRNewswire/ -- Genzyme Biosurgery (Nasdaq: GZBX)
President Duke Collier will provide a business update and an overview of the
biosurgery marketplace in a presentation on Tuesday, January 8 at the
JPMorgan H&Q 20th Annual Healthcare Conference in San Francisco.
The presentation will take place at 8 a.m. PST at the Westin St. Francis
Hotel in the Elizabethan C & D room. The presentation will be webcast live
and archived until January 15 at http://www.genzyme.com/ir/events.htm.
Genzyme Biosurgery is a leader in the emerging market for implantable
therapeutics. Its products and pipeline are concentrated in the rapidly
growing markets of orthopaedics and heart disease, and in broader surgical
applications. Genzyme Biosurgery is a division of Genzyme Corp.
Genzyme's press releases and other company information are available at
http://www.genzyme.com and by calling Genzyme's investor information line at
1-800-905-4369 within the United States or 703-797-1866 outside the United
States.
Media Contact: Investor Contact:
Dan Quinn Kristen Galfetti
617-591-5849 617-761-8563
SOURCE Genzyme Biosurgery
 back to top
Related links:
http://www.genzyme.com
CONTACT:
Media: Dan Quinn, +1-617-591-5849, or
Investor: Kristen Galfetti, +1-617-761-8563, both of Genzyme
|
